SPINK2 - Spink2 serine peptidase inhibitor, Kazal type 2 Gene
Species: Rattus norvegicus
Summary
Predicted to enable serine-type endopeptidase inhibitor activity. Predicted to be involved in acrosome assembly and negative regulation of serine-type endopeptidase activity. Predicted to act upstream of or within several processes, including fertilization; gamete generation; and seminiferous tubule development. Predicted to be located in acrosomal vesicle and neuron projection. Human ortholog(s) of this gene implicated in spermatogenic failure 29. Orthologous to human SPINK2 (serine peptidase inhibitor Kazal type 2). [provided by Alliance of Genome Resources, Apr 2022]
SPINK2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001008870.2 | NP_001008870.1 | serine protease inhibitor Kazal-type 2 precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
serine protease inhibitor Kazal-type 2 |
|
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P991676 | Eflumenibep alfa | Inhibitor | 97.52% | Phase 2 |
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS13680 | SPINK2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS20600 | Spink2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS27108 | Spink2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service